68 Views | 23 Downloads
Steven J. Katz, MD, MPH, Departments of Medicine and, Health Management and Policy, University of Michigan Medicine, North Campus Research Complex, 2800 Plymouth Rd, B16 Rm 410E, Ann Arbor, MI 48109-2800; e-mail: skatz@med.umich.edu
We thank Jill S. Dolinsky, CGC, and Melissa Pronold at Ambry Genetics, Delores Bowman and Benjamin Solomon at GeneDx, Edward Esplin and Stephen Lincoln at Invitae, and Johnathan Lancaster and Brian Dechairo at Myriad Genetics for their collaboration on the genetic test data linkage to SEER data. Written permission was obtained to include the names of all acknowledged individuals.
Conception and design: Steven J. Katz, Kevin C. Ward, Allison W. Kurian. Financial support: Steven J. Katz. Administrative support: Steven J. Katz. Provision of study materials or patients: Ann S. Hamilton. Collection and assembly of data: Steven J. Katz, Kevin C. Ward, Ann S. Hamilton, Paul Abrahamse, Sarah T. Hawley. Data analysis and interpretation: Steven J. Katz, Kevin C. Ward, Paul Abrahamse, Allison W. Kurian. Manuscript writing: All authors. Final approval of manuscript: All authors. Accountable for all aspects of the work: All authors.
Allison W. Kurian Research Funding: Myriad Genetics
Supported by Grant No. P01 CA163233 to the University of Michigan from the National Cancer Institute. Conducted work was also supported by the University of Michigan Cancer Center Biostatistics, Analytics and Bioinformatics shared resource (P30CA46592). The collection of Los Angeles County cancer incidence data used in this study was supported by the California Department of Public Health pursuant to California Health and Safety Code Section 103885, Centers for Disease Control and Prevention’s (CDC’s) National Program of Cancer Registries, under cooperative agreement 5NU58DP003862-04/DP003862, the National Cancer Institute’s SEER Program under contract HHSN261201000140C awarded to the Cancer Prevention Institute of California, contract HHSN261201000035C awarded to the University of Southern California, and contract HHSN261201000034C awarded to the Public Health Institute. The collection of cancer incidence data in Georgia was supported by contract HHSN261201300015I, Task Order HHSN26100006 from the National Cancer Institute and cooperative agreement 5NU58DP003875-04-00 from the CDC.
© 2018 by American Society of Clinical Oncology